STOCKS TELEGRAPH

Tag: ECOR

  • The Three Best Financial Stocks for Investment

    The Three Best Financial Stocks for Investment

    The financial stocks are expected to perform better in 2021.

    Since the evolution of the internet, the financial sector has grown and has become a much bigger and enhanced marketplace for payments and other financial services. Banks that are the bigger part of this industry haven’t had a good time in 2020, whereas, online banking services and payment firms have made gains.

    Analysts see financial stocks making a sharp rebound in 2021 and beyond with things getting better—in the longer run. But an investment in the market’s best financial stocks could pay off handsomely this year. So, let’s have a look at the three best financial stocks for investment in 2021.

    Goldman Sachs (GS)

    Goldman Sachs (GS) is one of the market leaders and is a strong financial firm that has some impeccable operations. The company has performed quite well compared to the rest of the industry firms.

    During the full-year 2020, the company remained focused on serving clients and executing strategic priorities and generated net revenues of $44.56 billion, up by 22% year-over-year. This marked the highest annual net revenues in 11 years, which is quite an achievement. While the diluted EPS was $24.74, the second-highest EPS reported by the company in its history.

    Goldman Sachs (GS) is well on track and this year things are expected to grow with continuous momentum. So, GS stock is for sure one of the best investment options in the financial sector.

    Nelnet (NNI)

    Nelnet (NNI) is a US-firm that deals in the administration and repayment of student loans and education financial services. Nelnet has been one of the top performers in the financial sector during the past year.

    As of the third quarter, the Company recorded GAAP net income of $71.5 million, which was higher than the prior year’s net income of $33.2 million. The increase in net income was primarily driven by the rise in loan spread and the recognition of a negative provision for loan losses during Q3 on Nelnet’s loan portfolio. Moreover, the company gained recognition from the sale of consumer loans.

    The company is continuing to perform well and has been making some strategic collaborations. The best part is that they have received customer-focused responses from their operating businesses during the pandemic, which has really boosted things up. In the long-term, the launch of Nelnet Bank and third-party investment received by ALLO will play a massive role in the firm’s growth. So, NNI is another prominent stock for investment.

    Credit Acceptance (CACC)

    Credit Acceptance (CACC) is an auto finance company that provides automobile loans and other related financial products. CACC operates its financial program via a network of national dealer-partners and the automobile dealers’ part of its programs.

    In the last quarter report, the company reported a net income of $166.3 million during Q4 2020, compared to $161.9 million in 2019. Whereas, for the full-year, the company recorded a net income of $421 million, on a lower side from last year which was $656.1 million.

    Recently, the company completed a $500 million asset-backed non-recourse secured financing. The company will use this financing to repay outstanding indebtedness. Earlier this year, Credit Acceptance completed similar financing worth $100 million.

    Credit Acceptance (CACC) shares have been on the downward side since mid-2020. However, with improvement in the Q4 results, thereis much upside expected as we head forward.

  • The Two Best Home Improvement Stocks to Buy Now

    The Two Best Home Improvement Stocks to Buy Now

    The home improvement stocks to look forward to in 2021.

    The home improvement stocks once again must be on investor’s radar. The global pandemic has prolonged and does not seem to ease off. In the meantime, people spend most of their time at home—having much time to observe and identify the room for improvement.

    We have various companies that are working quite well in this sector and have much potential in the future. The increase spent on revamping the inside infrastructure has spiked during the COVID-19 era. This inclination in demand has played out as an upside for several companies in the home improvements space. So, there are certain key stocks to keep on your watch list. Here are the two best home improvement stocks to buy now.

    Lowe’s Companies (LOW)

    Lowe’s Companies (LOW) a US-based company that specializes in home improvement. The company is among Zacks’ top-ranked firms that are up to the standard. The three factors that could make Lowe’s a good investment option are:

    The first one is earnings growth. For any company, the earnings growth is a top indicator to judge the stock’s position and future potential. The historical EPS growth rate for Lowe’s is 17.6%, though the investors must know what’s up next. For this year, Lowe’s EPS is forecasted to have a growth rate of 52.4%, bamboozling the industry average quite extraordinarily, which is anticipated to be 14.8%.

    The second important factor is its impressive asset utilization ratio. It’s quite important and growth investors often overlook this aspect. The company has aS/TA ratio of 1.82, which means that Lowe’s earns $1.82 in sales for each dollar in assets. Whereas, the average industry rate stands at $1.67. So, Lowe’s tops the industry in this regard, as well.

    Moreover, the last important factor is the continuous revision of earnings estimates, which have been moving upwards. Zacks earnings estimate for 2021 has soared 0.1% over the first four weeks of 2021.

    Lumber Liquidators (LL)

    Lumber Liquidators (LL) is a holding company that has multi-channels with retailers in hardwood flooring, and hardwood flooring enhancements and accessories. The company has been performing well and the quarterly results have improved quite well during the pandemic.

    The company saw a rise in sales trends with sequential improvement in its Pro and Install customers. For the first half of 2020, the company saw a notable rise in demands, which continued into the next quarters. In Q3, the company reported revenues of $295.83 million, beating Zacks estimates by 3.55% and $263.96 million year-over-year. The quarterly earnings per share came in at $0.67, more than double of Zacks’ estimates of $0.30 per share. While it was a skyrocketing jump from the prior-year earnings of $0.08. At the moment, the outlook is quite positive and LL lies in the range of the buy zone.

  • 21 Stocks Taking Bigger Strides in Pre Market Session

    21 Stocks Taking Bigger Strides in Pre Market Session

    ‎Velodyne Lidar Inc. (VLDR) stock soared 7.5% to $26.53 in the pre-market trading ‎after reporting that it has joined the Qualcomm® Smart Cities Accelerator Program to promote using ‎lidar technology in smart city solutions. The most recent rating by Needham, on December 15, 2020, is ‎a Buy. ‎

    ‎MicroVision Inc. (MVIS) grew over 14.38% at $6.6 in pre-market trading today.‎

    ‎Aurora Mobile Limited (NASDAQ: JG) shares are trading up 48.9% at $4.75 at the ‎time of writing following the announcement from the firm that it has entered into a partnership ‎agreement with a global leading new energy vehicle manufacturer. Company’s 52-week ranged ‎between $1.40 to $5.43.‎

    ‎Castor Maritime Inc. (CTRM) stock moved down -3.97 percent to $0.1522 in the pre-‎‎‎‎market trading.‎

    ‎HEXO Corp. (HEXO), a Drug Manufacturers – Specialty & Generic company, rose ‎about 8.0% at $1.08 in pre-market trading Tuesday after reporting lapse of base shelf prospectus.‎

    ‎Novan Inc. (NOVN) stock plunged -5.8% to $0.6396 in the pre-market trading after ‎declaring that it has entered into a Master Services Agreement (MSA) with Catalent.‎

    ‎Nano Dimension Ltd. (NNDM) gained over 2.38% at $8.61 in pre-‎‎‎market ‎trading ‎Tuesday December 22, 2020.‎

    ‎Gevo Inc. (NASDAQ: GEVO) shares are trading up 8.39% at $3.1 at the time of ‎writing following the declaration from the company that it has optioned the right to purchase ‎approximately 239 acres of land near Lake Preston, SD Company’s 52-week ranged between $0.46 to ‎‎$2.87. Gevo Options Site for Expansion Project.‎

    ‎electroCore Inc. (ECOR) gained over 7.36% at $1.75 in pre-market trading Tuesday ‎December 22, 2020 after reporting agreement with Pro Medical Baltic to be exclusive distributor for ‎gammaCore Sapphire in Eastern Europe.‎

    ‎Nxt-ID Inc. (NXTD), a Security & Protection Services company, dropped about -‎‎‎‎4.41% at $1.3 in pre-market trading Tuesday.‎

    ‎Iterum Therapeutics plc (NASDAQ: ITRM) shares are trading up 2.35% at $1.0 at the ‎time of writing after receiving approval to transfer to Nasdaq Capital Market. Company’s 52-week ‎ranged between $0.45 to $6.47. Analysts have a consensus price target of $2. ‎

    ‎Aurora Cannabis Inc. (ACB) stock moved up 2.13 percent to $9.13 in the pre-‎‎‎market ‎trading.‎

    ‎Venus Concept Inc. (VERO) tumbled over -16.14% at $2.13 in pre-market trading ‎today following the announcement of proposed public offering.‎

    ‎UP Fintech Holding Limited (NASDAQ: TIGR) shares are trading up ‎‎7.97% ‎at ‎‎$6.37 ‎at ‎the time of writing. Company’s 52-week ranged between $2.03 to $7.60.‎

    ‎IZEA Worldwide Inc. (IZEA) lost over -1.78% at $1.38 in pre-‎‎market ‎trading ‎Tuesday ‎December 22, 2020.‎

    ‎500.com Limited (WBAI), a Gambling company, rose about 9.14% at $4.18 in pre-‎market trading Tuesday following the declaration from the firm that it has entered into a definitive ‎share subscription agreement with Good Luck Information Technology Co., Limited , a company ‎incorporated in Hong Kong, for the issuance and sale of newly issued Class A ordinary shares of the ‎Company.‎

    ‎Liminal BioSciences Inc. (LMNL) stock soared 2.76% to $5.21 in the pre-‎‎‎market ‎trading. The most recent rating by Piper Sandler, on December 21, 2020, is an Overweight.‎

    ‎Palantir Technologies Inc. (PLTR) gained over 1.72% at $29.0 in pre-market trading ‎Tuesday December 22, 2020 after declaring that the U.S. Army’s Program Executive Office for ‎Enterprise Information Systems (PEO EIS) opted to execute the second year of its partnership with ‎Palantir on the Army Vantage program, for a total price of $113.8 million for the year.‎

    ‎EyeGate Pharmaceuticals Inc. (EYEG) is down more than -3.84% at $5.01 in pre-‎market hours Tuesday December 22, 2020 after announcing the acquisition of Panoptes Pharma. The ‎stock had jumped over 45.94% to $5.21 in the last trading session. ‎

    Before the trading started on December 22, 2020, Kopin Corporation (KOPN) ‎is ‎up ‎‎8.43% to reach $2.83. It has been trading in a 52-week range of $0.19 to $2.16.‎

    ‎Bit Digital Inc. (BTBT) grew over 4.96% at $6.56 in pre-market trading today following ‎the release of its third quarter of fiscal year 2020 financial results.‎

  • Pre Market Report: Stock Watch Ahead Of U.S Markets Opening

    Pre Market Report: Stock Watch Ahead Of U.S Markets Opening

    U.S markets are showing signs of a rebound after a weak showing in Monday’s session. Nonetheless, market sentiment remains mixed. On the downside, there are fears that the economy could be headed for another shutdown as the coronavirus numbers continue to rise. States like California are slowing down on reopening to curtail the virus spread. There are also concerns about equities being overpriced. Most companies have taken a hit in their revenues, yet the stock market has rallied back to pre-crisis levels. This indicates a disconnect between stock market valuations and corporate performance. On the positive side, the U.S government appears ready to keep supporting the economy. Today, The New York Times has reported that the Trump administration is calling for a payroll tax cut, relief for distressed industries, and a tax holiday on capital gains. The New York Times further states that the next stimulus could be between $1 trillion to $3 trillion. While this adds to the already ballooning deficit, it offers critical support to the economy, and more specifically the equity markets.  In spite of the mixed outlook, there are stocks that are on a roll pre-market and could perform well in the day. Some of them are as below.

    Tesla [NASDAQ: TLSA]

    Tesla continues its stellar performance and is up by over 6% pre-market. The stock has been on an exponential growth path driven by its sales numbers, and a growing appetite for stocks in the market. Tesla recently announced that in Q2, it had delivered 90,650 units, beating its estimates of 74,130 units.  Some analysts believe that this points to growing demand for the company’s vehicles, which is playing to support its stock price. A JP Morgan recently stated that Tesla was now set to break even on GAAP in Q2, a factor that is changing the market’s risk evaluation of the stock. With such optimism at play, TLSA could continue its rally if the market opens in positive territory.

    INmune Bio Inc [NASDAQ: INMB]

    INmune Bio is another big mover pre-market and is up by 142.82% at the time of writing. The rally comes hours after the company released interim data showing that its treatment called XPro1595 reduces neuroinflammation in people suffering from Alzheimer’s disease. XPro1595 is an inhibitor for tumor necrosis factor that neutralizes soluble TNF, and with implications on the pathology of Alzheimer’s. Commenting on the results, the company’s director of neuroscience, CJ Barnum stated that they were happy with the findings. The response the stock has received pre-market shows that investors are optimistic that this could be a major breakthrough not just for Alzheimer’s patients, but also for the company’s bottom-line.

    ElectroCore Inc [NADAQ: ECOR]

    ElectroCore was a top gainer in yesterday’s session and closed with gains of 109.41%. The stock seems poised to continue this rally and is up by 6% in pre-market trading. The upside momentum is driven by the company’s announcement that it had received emergency use authorization from the FDA for its COVID-19 treatment.  The company stated that it was now working on making its new therapy available to medics treating COVID-19 patients that have asthma and other breathing difficulties,